After completing his PhD at the University of Colorado Boulder, Joel led the lab buildout and assay development of a first-to-market product at a startup CRO. In his current role as the Director of Operations at Enveda Biosciences, he has overseen the development of multiple new R&D facilities.
Reservation Policy & Attendance Limit: This event has an attendance limit of 300 people and seats will be reserved on a first-come, first-served basis. Please be sure to register as soon as possible to reserve your seat and ensure your attendance.
*We strive to be inclusive. All are welcome to attend!